Trials / Completed
CompletedNCT01816295
A Study in Men With Low Testosterone to Measure the Effects of Testosterone Solution on Testosterone Levels, Sex Drive and Energy
A Randomized, Double-Blind, Placebo-Controlled Parallel Study With an Open-Label Extension to Assess the Impact of Testosterone Solution on Total Testosterone, Sex Drive and Energy in Hypogonadal Men
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 715 (actual)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The main purpose of this study is to evaluate if testosterone solution can raise testosterone hormone levels into the normal range, and also improve levels of sexual arousal, interest and drive and/or energy level, in men with low testosterone and decreased sexual arousal, interest and drive and/or decreased energy. The study will last about 16 weeks, followed by an optional 24 week open label treatment phase to investigate the long term safety of testosterone solution.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Testosterone Solution | Administered topically to axillae. |
| DRUG | Placebo Solution | Administered topically to axillae. |
Timeline
- Start date
- 2013-05-01
- Primary completion
- 2014-10-01
- Completion
- 2015-04-01
- First posted
- 2013-03-22
- Last updated
- 2015-12-28
- Results posted
- 2015-10-02
Locations
85 sites across 9 countries: United States, Argentina, Canada, Germany, Italy, Puerto Rico, South Korea, Spain, United Kingdom
Source: ClinicalTrials.gov record NCT01816295. Inclusion in this directory is not an endorsement.